Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
$2.32
0.041.75%
Last update: Dec 12, 12:54 PM
Comments
Loading...
Aytu BioPharma Analyst Ratings and Price Targets | NASDAQ:AYTU | Benzinga
Aytu BioPharma Inc has a consensus price target of $12 based on the ratings of 4 analysts. The high is $20 issued by HC Wainwright & Co. on May 31, 2023. The low is $7 issued by Maxim Group on September 25, 2025. The 3 most-recent analyst ratings were released by Ascendiant Capital, Maxim Group, and Ascendiant Capital on December 10, 2025, September 25, 2025, and September 25, 2025, respectively. With an average price target of $10.83 between Ascendiant Capital, Maxim Group, and Ascendiant Capital, there's an implied 366.95% upside for Aytu BioPharma Inc from these most-recent analyst ratings.
Analyst Firms Making Recommendations1
Ascendiant Capital
Maxim Group
Lake Street
HC Wainwright & Co.
1calculated from analyst ratings
Analyst Ratings for Aytu BioPharma
FAQ
What is the target price for Aytu BioPharma (AYTU) stock?
The latest price target for Aytu BioPharma (NASDAQ:AYTU) was reported by Ascendiant Capital on December 10, 2025. The analyst firm set a price target for $13.00 expecting AYTU to rise to within 12 months (a possible 460.34% upside). 5 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for Aytu BioPharma (AYTU)?
The latest analyst rating for Aytu BioPharma (NASDAQ:AYTU) was provided by Ascendiant Capital, and Aytu BioPharma maintained their buy rating.
When was the last upgrade for Aytu BioPharma (AYTU)?
There is no last upgrade for Aytu BioPharma
When was the last downgrade for Aytu BioPharma (AYTU)?
There is no last downgrade for Aytu BioPharma.
When is the next analyst rating going to be posted or updated for Aytu BioPharma (AYTU)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Aytu BioPharma, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Aytu BioPharma was filed on December 10, 2025 so you should expect the next rating to be made available sometime around December 10, 2026.
Is the Analyst Rating Aytu BioPharma (AYTU) correct?
While ratings are subjective and will change, the latest Aytu BioPharma (AYTU) rating was a maintained with a price target of $12.50 to $13.00. The current price Aytu BioPharma (AYTU) is trading at is $2.32, which is out of the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.
